The journal of ECT

Managing Electroconvulsive Therapy in Patients Taking GLP-1 Diabetes Drugs: Balancing Safety, Treatment Following, and Consistency

Updated

Abstract

A patient with refractory major depressive disorder on tirzepatide completed 17 ECT treatments without complications.

  • Electroconvulsive therapy (ECT) is generally performed under general anesthesia, which can risk aspiration in patients with retained gastric contents.
  • Patients taking GLP-1 receptor agonists face challenges with standard fasting requirements before ECT.
  • A new pre-ECT fasting protocol was developed to improve safety and patient experience for those on GLP-1 receptor agonists.
  • The patient treated under this novel protocol demonstrated successful outcomes without complications.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free